miRNA-34a is associated with docetaxel resistance in human breast cancer cells (Q39576802)

13 September 2017

miRNA-34a is associated with docetaxel resistance in human breast cancer cells (English)

1 reference

13 September 2017

1 reference

1 reference

L Kastl

1

1 reference

13 September 2017

I Brown

series ordinal

2

1 reference

13 September 2017

A C Schofield

series ordinal

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

12 March 2011

1 reference

Breast Cancer Research and Treatment

13 September 2017

1 reference

13 September 2017

131

1 reference

13 September 2017

2

1 reference

13 September 2017

445-454

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1424-3

13 September 2017

0 references

cites work

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Prediction of response to docetaxel by immunohistochemical analysis of CYP3A4 expression in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Predictive factors for response to docetaxel in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

How microRNAs control cell division, differentiation and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

The microRNA (miRNA): overview of the RNA genes that modulate gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Expression patterns of cell cycle and apoptosis-related genes in a multidrug-resistant human colon carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Different roles for cyclins D1 and E in regulation of the G1-to-S transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1424-3

10.1007/S10549-011-1424-3

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference